This HTML5 document contains 287 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
dbpedia-dehttp://de.dbpedia.org/resource/
dbpedia-shhttp://sh.dbpedia.org/resource/
dcthttp://purl.org/dc/terms/
yago-reshttp://yago-knowledge.org/resource/
dbohttp://dbpedia.org/ontology/
foafhttp://xmlns.com/foaf/0.1/
n18https://global.dbpedia.org/id/
umbel-rchttp://umbel.org/umbel/rc/
yagohttp://dbpedia.org/class/yago/
dbthttp://dbpedia.org/resource/Template:
rdfshttp://www.w3.org/2000/01/rdf-schema#
dbpedia-ukhttp://uk.dbpedia.org/resource/
dbpedia-svhttp://sv.dbpedia.org/resource/
n23http://adisinsight.springer.com/drugs/
n11http://www.ontologydesignpatterns.org/ont/dul/DUL.owl#
dbpedia-srhttp://sr.dbpedia.org/resource/
freebasehttp://rdf.freebase.com/ns/
dbpedia-pthttp://pt.dbpedia.org/resource/
n15http://commons.wikimedia.org/wiki/Special:FilePath/
dbpedia-fahttp://fa.dbpedia.org/resource/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
owlhttp://www.w3.org/2002/07/owl#
dbpedia-ithttp://it.dbpedia.org/resource/
wikipedia-enhttp://en.wikipedia.org/wiki/
dbphttp://dbpedia.org/property/
dbchttp://dbpedia.org/resource/Category:
provhttp://www.w3.org/ns/prov#
xsdhhttp://www.w3.org/2001/XMLSchema#
wikidatahttp://www.wikidata.org/entity/
goldhttp://purl.org/linguistics/gold/
dbrhttp://dbpedia.org/resource/

Statements

Subject Item
dbr:Buserelin
rdf:type
dbo:ChemicalSubstance yago:Matter100020827 yago:Peptide114743046 n11:ChemicalObject yago:OrganicCompound114727670 yago:Unit109465459 yago:Substance100019613 yago:Abstraction100002137 umbel-rc:DrugProduct yago:WikicatPeptides yago:Part113809207 dbo:Drug yago:Molecule114682133 yago:Amide114724264 yago:Macromolecule114944888 yago:PhysicalEntity100001930 yago:Material114580897 yago:Relation100031921 wikidata:Q8386 owl:Thing yago:Chemical114806838 yago:Protein114728724 yago:Thing100002452 yago:Compound114818238
rdfs:label
Buserelina Buserelinacetat Buserelina Бусерелін Buserelin Buserelin
rdfs:comment
Buserelinacetat är det vanligaste medlet i den grupp läkemedel som på engelska kallas Gonadotropin releasing hormone analogue, GnRH-analoger. I Sverige säljs buserelinacetet under handelsnamnet Receptal (veterinärmedicinskt) respektive Suprefact (medicinskt). Medlen är syntetiska peptidpreparat utformade med hormonet GnRH, som utsöndras från hypotalamus, som modell. Dess främsta användningsområde hos människor är som behandling vid prostatacancer, då medlet minskar testosteronhalten hos män. Buserelina é um fármaco. Promove a estimulação da produção do hormônio luteinizante (LH) e do hormônio folículo-estimulante (FSH). É utilizado como anticoncepcional, na endometriose e no carcinoma de próstata. Бусерелін (англ. Buserelin, лат. Buserelinum) — синтетичний лікарський препарат, який за своєю хімічною будовою є поліпептидом та аналогом гонадотропін-рилізинг гормону, та застосовується як перорально, так і внутрішньом'язово, підшкірно та внутрішньовенно, а також інтраназально. Бусерелін синтезований у 1976 році, та застосовується у клінічній практиці з 1984 року. Buserelin, sold under the brand name Suprefact among others, is a medication which is used primarily in the treatment of prostate cancer and endometriosis. It is also used for other indications such as the treatment of premenopausal breast cancer, uterine fibroids, and early puberty, in assisted reproduction for female infertility, and as a part of transgender hormone therapy. In addition, buserelin is used in veterinary medicine. The medication is typically used as a nasal spray three times per day, but is also available for use as a solution or implant for injection into fat. La buserelina è un ormone di rilascio delle gonadotropine ed è un agonista del GnRH. Il buserelin acetato è commercializzato da Sanofi-Aventis con il marchio Suprefact ma è anche disponibile il generico. Buserelin ist die Abkürzung für Butylserylrelin und beschreibt einen hormonell wirksamen Arzneistoff, der als GnRH-Analogon wirkt.
foaf:depiction
n15:Buserelin.svg n15:Buserelin_molecule_ball.png
dct:subject
dbc:GnRH_agonists dbc:Puberty_blockers dbc:Peptides dbc:World_Anti-Doping_Agency_prohibited_substances dbc:Hormonal_antineoplastic_drugs
dbo:wikiPageID
2102388
dbo:wikiPageRevisionID
1093081712
dbo:wikiPageWikiLink
dbr:Female_infertility dbr:Synthetic_compound dbr:Bone_pain dbc:GnRH_agonists dbr:Puberty_blocker dbr:Transgender_youth dbr:Erectile_dysfunction dbr:Symptom dbr:Peptidase dbr:Gonadotropin-releasing_hormone_analogue dbr:Menorrhagia dbr:Overdose dbr:Cancer dbr:Hypersensitivity dbr:Subcutaneous_injection dbr:Free_base dbr:Nasal_spray dbr:GnRH_analogue dbr:Australia dbr:Endometrial_hyperplasia dbr:Nonapeptide dbr:Premenopause dbr:Elimination_half-life dbr:Sexual_dysfunction dbr:Bile dbr:United_Kingdom dbr:Kidney dbr:Teratogen dbr:Nafarelin dbr:Menopause dbr:Europe dbr:Libido dbr:Solution_(chemistry) dbr:Agonist dbr:Sanofi-Aventis dbr:Headache dbr:Follicle-stimulating_hormone dbr:Asthenia dbr:Hypoestrogenism dbr:GnRH_agonist dbr:Uterine_fibroid dbr:Vaginal_dryness dbc:Puberty_blockers dbr:Canada dbr:Dizziness dbr:Subcutaneous_implant dbr:Route_of_administration dbr:South_Africa dbr:Hormone-dependent_cancer dbr:Ovulation_induction dbr:Generic_term dbr:Contraindication dbr:Gonadotropin-releasing_hormone_agonist dbr:Vaginal_atrophy dbr:Hormone-responsive_cancer dbc:Peptides dbr:Testicle dbr:Asia dbr:Spermatogenesis dbr:Side_effect dbr:Veterinary_medicine dbr:GnRH_receptor dbr:Acetate dbr:Metabolism dbr:Pyroglutamyl_peptidase dbr:Prostate_cancer dbr:Tumor dbr:Oligozoospermia dbr:Anovulation dbr:Anaphylaxis dbr:Hot_flash dbr:Sex_hormone dbr:Metabolite dbr:Hormonal_contraceptive dbr:Hypoandrogenism dbr:Testosterone dbr:Bioavailability dbr:Progesterone dbr:Gonadotropin dbr:Biosynthesis dbr:Emotional_lability dbr:Uterine_fibroids dbr:Gonadotropin-releasing_hormone_receptor dbr:Abnormal_vaginal_bleeding dbr:Off-label_use dbr:New_Zealand dbr:Elimination_(pharmacology) dbr:Gastrointestinal_tract dbr:Intravenous_therapy dbr:Metastasis dbr:Oral_administration dbr:Hypogonadism dbr:Hypogonadotropic_hypogonadism dbr:Anterior_pituitary dbr:Superagonist dbr:Downregulation_and_upregulation dbr:Urinary_retention dbr:Cyproterone_acetate dbr:Pregnancy dbr:Secretion dbc:World_Anti-Doping_Agency_prohibited_substances dbr:Oligospermia dbr:Liver dbr:Endogenous dbr:Gonadectomy dbr:First-pass_metabolism dbr:Gonad dbr:Assisted_reproduction dbr:Estradiol dbr:Uterine_disease dbr:Urine dbr:Gonadotroph dbr:Steroidal_antiandrogen dbr:Pituitary_gland dbr:Ireland dbr:Chymotrypsin-like_endopeptidase dbr:Peptide dbr:Osteoporosis dbr:Azoospermia dbr:Bloodstream dbr:Castration dbr:Depression_(mood) dbr:Drug dbr:Downregulation dbr:Excretion dbr:Intranasal_administration dbr:Luteinizing_hormone dbc:Hormonal_antineoplastic_drugs dbr:United_States dbr:Antigonadotropin dbr:Latin_America dbr:Structural_analog dbr:Adrenal_gland dbr:Breast_cancer dbr:Precocious_puberty dbr:Absorption_(pharmacokinetics) dbr:Endometriosis dbr:Salt_(chemistry) dbr:Transgender_hormone_therapy dbr:Adjunct_therapy dbr:Hoechst_AG dbr:Generic_medication dbr:Plasma_protein_binding dbr:Breastfeeding dbr:Luteal_phase dbr:CinnaGen dbr:Potency_(pharmacology)
dbo:wikiPageExternalLink
n23:800043601
owl:sameAs
dbpedia-uk:Бусерелін dbpedia-it:Buserelina dbpedia-de:Buserelin n18:3qVgi dbpedia-sv:Buserelinacetat freebase:m.06m8lm dbpedia-sr:Buserelin yago-res:Buserelin dbpedia-pt:Buserelina dbpedia-sh:Buserelin dbpedia-fa:بوسرلین wikidata:Q414745
dbp:wikiPageUsesTemplate
dbt:Ebicite dbt:Drugbankcite dbt:GnRH_and_gonadotropins dbt:Drugbox dbt:ATCvet dbt:Fdacite dbt:Stdinchicite dbt:Cite_journal dbt:Abbrlink dbt:Reflist dbt:Chemspidercite dbt:Cascite dbt:Drugs.com dbt:GnRH_and_gonadotropin_receptor_modulators
dbo:thumbnail
n15:Buserelin.svg?width=300
dbp:atcSuffix
AE01
dbp:atcPrefix
L02
dbp:bioavailability
Subcutaneous: 70% Intranasal: 2.5–3.3% Oral: ineffective
dbp:c
60
dbp:casNumber
57982
dbp:casSupplemental
68630
dbp:chebi
135907
dbp:chembl
2110824
dbp:chemspiderid
45545
dbp:class
dbr:GnRH_analogue dbr:Antigonadotropin dbr:GnRH_agonist
dbp:drugbank
DB06719
dbp:eliminationHalfLife
-4800.0 -7200.0 4800.0
dbp:excretion
dbr:Urine dbr:Bile
dbp:h
86
dbp:image
Buserelin molecule ball.png
dbp:iupacName
-N-[-1-[[-1-[[-1-[[-1-[[-1-[[-1-[[-5--1-[-2-pyrrolidin-1-yl]-1-oxopentan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-3-[oxy]-1-oxopropan-2-yl]amino]-3--1-oxopropan-2-yl]amino]-3-hydroxy-1-oxopropan-2-yl]amino]-3--1-oxopropan-2-yl]amino]-3--1-oxopropan-2-yl]-5-oxopyrrolidine-2-carboxamide
dbp:legalStatus
Rx-only
dbp:metabolism
Liver, kidneys, gastrointestinal tract
dbp:n
16
dbp:o
13
dbp:pregnancyCategory
X
dbp:pubchem
50225
dbp:routesOfAdministration
dbr:Nasal_spray dbr:Subcutaneous_injection dbr:Subcutaneous_implant
dbp:smiles
CCNC[C@@H]1CCCN1C[C@H]NC[C@H]NC[C@@H]NC[C@H]NC[C@H]NC[C@H]NC[C@H]NC[C@@H]6CCCN6
dbp:stdinchi
1
dbp:stdinchikey
CUWODFFVMXJOKD-UVLQAERKSA-N
dbp:synonyms
Etilamide; HOE-766; HOE-766A; ICI-123215; S-746766; (D)-Ser6EA10-LHRH; 6-[O--(D)-serine]-9--10-deglycinamide-LHRH
dbp:tradename
Suprefact, others
dbp:unii
PXW8U3YXDV
dbp:verifiedfields
verified
dbp:verifiedrevid
477165149
dbp:watchedfields
verified
dbp:width
235 225
dbo:abstract
La buserelina è un ormone di rilascio delle gonadotropine ed è un agonista del GnRH. Il buserelin acetato è commercializzato da Sanofi-Aventis con il marchio Suprefact ma è anche disponibile il generico. Buserelin, sold under the brand name Suprefact among others, is a medication which is used primarily in the treatment of prostate cancer and endometriosis. It is also used for other indications such as the treatment of premenopausal breast cancer, uterine fibroids, and early puberty, in assisted reproduction for female infertility, and as a part of transgender hormone therapy. In addition, buserelin is used in veterinary medicine. The medication is typically used as a nasal spray three times per day, but is also available for use as a solution or implant for injection into fat. Side effects of buserelin are related to sex hormone deprivation and include symptoms of low testosterone levels and low estrogen levels such as hot flashes, sexual dysfunction, vaginal atrophy, and osteoporosis. Buserelin is a gonadotropin-releasing hormone agonist (GnRH agonist) and works by preventing the production of sex hormones by the gonads. It can lower sex hormone levels by about 95% in both sexes. Buserelin is a peptide and an analogue of GnRH. Buserelin was first patented in 1974 and approved for medical use in 1985. It is not available in the United States, but is marketed widely elsewhere in the world, including in the United Kingdom, Canada, and many other countries. The medication is one of only two medically used GnRH analogues that are available as nasal sprays, the other being nafarelin. Buserelin is available as a generic medication. Бусерелін (англ. Buserelin, лат. Buserelinum) — синтетичний лікарський препарат, який за своєю хімічною будовою є поліпептидом та аналогом гонадотропін-рилізинг гормону, та застосовується як перорально, так і внутрішньом'язово, підшкірно та внутрішньовенно, а також інтраназально. Бусерелін синтезований у 1976 році, та застосовується у клінічній практиці з 1984 року. Buserelina é um fármaco. Promove a estimulação da produção do hormônio luteinizante (LH) e do hormônio folículo-estimulante (FSH). É utilizado como anticoncepcional, na endometriose e no carcinoma de próstata. Buserelin ist die Abkürzung für Butylserylrelin und beschreibt einen hormonell wirksamen Arzneistoff, der als GnRH-Analogon wirkt. Buserelinacetat är det vanligaste medlet i den grupp läkemedel som på engelska kallas Gonadotropin releasing hormone analogue, GnRH-analoger. I Sverige säljs buserelinacetet under handelsnamnet Receptal (veterinärmedicinskt) respektive Suprefact (medicinskt). Medlen är syntetiska peptidpreparat utformade med hormonet GnRH, som utsöndras från hypotalamus, som modell. Dess främsta användningsområde hos människor är som behandling vid prostatacancer, då medlet minskar testosteronhalten hos män.
dbp:iupharLigand
3860
dbp:metabolites
Buserelin
dbp:proteinBound
15.0
gold:hypernym
dbr:Agonist
prov:wasDerivedFrom
wikipedia-en:Buserelin?oldid=1093081712&ns=0
dbo:wikiPageLength
35430
dbo:alternativeName
Suprefact, others
dbo:casNumber
68630-75-1 (acetate) 57982-77-1
dbo:chEBI
135907
dbo:chEMBL
2110824
dbo:drugbank
DB06719
dbo:fdaUniiCode
PXW8U3YXDV
dbo:pubchem
50225
dbo:class
dbr:GnRH_analogue dbr:GnRH_agonist dbr:Antigonadotropin
foaf:isPrimaryTopicOf
wikipedia-en:Buserelin